This paper will present a multi-region-multi-country model in which inter-regional knowledgespillovers determine the growth of regions. Key parameters in the model are the learningcapability of a region, and the exogenous rate of knowledge generation (R&D). The intensityof spillovers depends on...

Globalisation has resulted in the increased mobility and knowledge intensity of the ownership advantages of MNEs, which they increasingly seek to utilise in conjunction with the created-asset intensive location advantages of countries. We highlight that that the relative opportunity sets (and...

Abstract not available

not available

This paper first develops an explanation for the increasing popularity of strategic technology alliances, both globally, and by EU firms. It then evaluates, using data over the period 1980-1994, how private, non-subsidised cooperative agreements in R&D by EU firms has evolved, paying particular...

We derive the central differential equation of the neoclassical growth model for the case of a CES (constant elasticity of substitution) production function with perfect capital movement in terms of the debt/GDP ratio and estimate it in several ways for the United States and in a later step the...

FDI has attracted increasing interest from developing countries because of the perceived benefits in terms of the injection of capital, technology and knowledge. This article analyses the main analytical underpinnings concerning the inter-relationships between FDI and host country economic...

We argue that a conventional double dividend policy - defined as reduction of greenhouse gas emissions and unemployment through taxation of energy and CO2 emissions and subsidization of wage costs - and the aim of keeping international competitiveness intact are mutually exclusive concepts. It...

not available

In this paper we investigate the implications of permitting parallel imports ofpharmaceuticals produced by a monopoly, from one country to another. We use a modelwhere countries differ in the patients’ level of co-payment for buying pharmaceuticals, andpatients differ in the utility obtained...